KME have never released guidance, they seem to be creatures of habit and their AGMs are pretty predictable. So no surprises there was no guidance.
Currently trading on 6x EBITDA
Still seems very cheap for a global franchise with some innovative, world first offerings, and for which Mangement seem pretty confident of delivering on-going profit growth
Have come to expect though in this market someone would want to sell it down after a pretty good update
Ann: Chairman's Address to Shareholders, page-6
Add KME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
-0.010(2.99%) |
Mkt cap ! $18.47M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.0¢ | 32.0¢ | $2.199K | 6.811K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 47489 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 1644 | 1 |
View Market Depth
| Last trade - 15.33pm 23/07/2024 (20 minute delay) ? |
| KME (ASX) Chart |